Dow Down 0.17% Nasdaq Down 0.28%

Neurocrine Biosciences Inc. (NBIX)

-NasdaqGS
15.67 Down 0.40(2.49%) 4:00PM EDT
|After Hours : 15.67 Down 0.00 (0.03%) 4:37PM EDT
Prev Close:16.07
Open:16.09
Bid:15.03 x 600
Ask:17.17 x 100
1y Target Est:22.67
Beta:0.05
Earnings Date:Oct 27 - Oct 31 (Est.)
Day's Range:15.33 - 16.09
52wk Range:8.57 - 20.29
Volume:928,160
Avg Vol (3m):523,092
Market Cap:1.19B
P/E (ttm):N/A
EPS (ttm):-0.67
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NBIX

Comparison

Symbol% ChgMkt Cap
NBIXDown 2.49%1.19B
ABTDown 0.74%62.54B
LLYDown 0.75%69.50B
PFEDown 0.67%187.50B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):836.20
Ex-Dividend Date:29-Dec-95

Analysts

Annual EPS Est (Dec-14) :-0.81
Quarterly EPS Est (Sep-14) :-0.21
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):-1.48

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Neurocrine Biosciences, Inc. discovers, develops, and commercializes drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback